Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.
about
A human-curated annotation of the Candida albicans genome.Functional Divergence of Hsp90 Genetic Interactions in Biofilm and Planktonic Cellular StatesUnderstanding the Role of the Master Regulator XYR1 in Trichoderma reesei by Global Transcriptional AnalysiscDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol.A novel polyamide SL-A92 as a potential fungal resistance blocker: synthesis and bioactivities in Candida albicans.TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2.In vivo systematic analysis of Candida albicans Zn2-Cys6 transcription factors mutants for mice organ colonization.Species and condition specific adaptation of the transcriptional landscapes in Candida albicans and Candida dubliniensis.Transcription factor ADS-4 regulates adaptive responses and resistance to antifungal azole stressSTB5 is a negative regulator of azole resistance in Candida glabrataA fungal family of transcriptional regulators: the zinc cluster proteinsCoordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi.The Rbf1, Hfl1 and Dbp4 of Candida albicans regulate common as well as transcription factor-specific mitochondrial and other cell activitiesTranscription factor CCG-8 as a new regulator in the adaptation to antifungal azole stress.In vitro Antifungal Susceptibility Patterns of Candida Albicans from HIV and AIDS Patients Attending the Nylon Health District Hospital in Douala, Cameroon.The global regulator Ncb2 escapes from the core promoter and impacts transcription in response to drug stress in Candida albicans.Novel Regulatory Mechanisms of Pathogenicity and Virulence to Combat MDR in Candida albicans.Mechanisms of Antifungal Drug Resistance.Ncb2 is involved in activated transcription of CDR1 in azole-resistant clinical isolates of Candida albicans.Fluconazole resistance in Candida species: a current perspective.Activation of the multiple drug resistance gene MDR1 in fluconazole-resistant, clinical Candida albicans strains is caused by mutations in a trans-regulatory factor.Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.Drug susceptibilities of yeast cells are affected by membrane lipid composition.Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei.Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.Antifungal resistance and new strategies to control fungal infections.In silico analysis for transcription factors with Zn(II)(2)C(6) binuclear cluster DNA-binding domains in Candida albicansRegulation of the hypoxic response in Candida albicans.Identification and functional characterization of Rca1, a transcription factor involved in both antifungal susceptibility and host response in Candida albicans.The UPC2 promoter in Candida albicans contains two cis-acting elements that bind directly to Upc2p, resulting in transcriptional autoregulation.Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.Dal81 Regulates Expression of Arginine Metabolism Genes in Candida parapsilosis.
P2860
Q21145286-EC036F29-8E7D-4463-870B-6B16E04F2788Q28548001-556FA83A-F51C-4629-BFF6-EA279EF5AE47Q28604269-4B418AB0-4F31-43BA-8DD7-BF1ED9B4B0F8Q31143838-43F10AD5-E2F1-4F8A-8EE2-8586DE767BE4Q33557539-BDC29CA7-504D-40E6-B0F3-977044449004Q33559776-E4ED5862-5688-4FA0-BCBC-13EA474558D9Q34071444-463014A6-F8AA-46D1-AD23-0DF496C2BB52Q34645110-D580E628-6D27-45DC-9A6F-63D7B9FCAD32Q35960980-8EA0DFA6-3857-4838-9643-7E3B7BA0BE90Q36558417-858E84AC-E274-4E42-8A5C-5A885C53D22EQ36588772-631E9EE0-2227-4B8D-A1E1-1A57790953DEQ37371189-16316828-1767-4F68-87EF-7869170C97A8Q37522581-222966CB-C6E1-4470-A38F-36F7C3B14708Q37643592-650A1C03-590F-4A17-BF09-FA97FF5F9E6FQ37693048-9CC05A07-E789-4DFD-B335-663AF5AED564Q37739596-4F3A4226-2C7E-4480-A3C6-8ECF886603F4Q38155848-EBA20AD8-C35B-4067-A3CF-486E258EF30FQ38266675-D3725F3D-C12F-4B13-9A5D-C430D01AAA81Q38627814-92682381-5B99-4667-8531-0916FFA9963FQ39092120-ED3E88D6-25F8-42E6-BAA8-2F50FDFDB1EAQ39498564-FB89BC63-B885-4A66-9823-420C190BAE40Q39657935-4446A472-86F5-46E8-8EC1-A5A193A3EA96Q39671060-3F4B07BB-6853-42E1-992B-06105022AFA8Q39743425-D905E599-27E9-40BB-8456-36DFCDB20BD0Q39746465-8FE7462C-52E4-4B74-82F7-633F7ABB004FQ39751373-0265CE64-68FA-4726-ADF7-22A85C71623DQ39778456-B9A4D0BF-D312-46BB-87DC-CF24CAF1F20AQ41948763-73D43DD5-D1FF-46CC-9FFE-8BE7FDEC5747Q42271039-92CBBB7C-92B3-4529-BBE3-C82D5EA97E46Q42428468-9E16D36C-0AF8-44B2-95F7-B2D05C433C29Q42477429-81F1E73A-4958-48C6-82EA-9D7E8277D37AQ55038640-86194B31-8EBA-469D-AE3F-DB70DE561DDA
P2860
Isolation of a putative Candida albicans transcriptional regulator involved in pleiotropic drug resistance by functional complementation of a pdr1 pdr3 mutation in Saccharomyces cerevisiae.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@ast
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@en
type
label
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@ast
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@en
prefLabel
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@ast
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@en
P2860
P1476
Isolation of a putative Candid ...... n in Saccharomyces cerevisiae.
@en
P2093
P2860
P304
P407
P577
1999-01-01T00:00:00Z